A randomized controlled trial finds no clear benefit of adding bezlotoxumab to FMT in patients with IBD and recurrent C difficile infection.

Dow Jones futures rose premarket Monday as Bitcoin surged above $82,000. Tesla stock jumped on a price-target hike.

Google stock has gained 28% in 2024 but shares have ping-ponged since July amid fierce AI competition and antitrust worries.

Not everyone responds equally well to treatments for inflammatory bowel disease (IBD). What will work for individual patients ...

Aeglea Biotherapeutics Inc. ( (SYRE) ) has released its Q3 earnings. Here is a breakdown of the information Aeglea Biotherapeutics Inc.

Developing a vaccination program for infectious bursal disease virus (IBDV) challenges should consider the severity and ...

Abu Dhabi, UAE: Sheikh Shakhbout Medical City (SSMC), one of the UAE’s largest hospitals for serious and complex care and a ...

Direct costs associated with IBD include ambulatory visits to gastroenterologists, emergency department visits, admissions ...

New research from ACG 2024 reveals that primary sclerosing cholangitis raises colorectal cancer risk even in patients without ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, insights, and strategies to pursue value-driven solutions.

Anticipation builds for Indias Best Dancer Season 4 finale with Arjun Kapoor and Tiger Shroff. Expect thrilling performances and a unique team challenge.